在心力衰竭住院治疗期间实施指南导向医疗治疗的决定因素
Emily Margolin1, Trina Huynh2, Alison Brann1,3
1Departments of Medicine, University of California-San Diego, San Diego, California, USA.
JACC. Advances
|August 12, 2024
概括
在住院期间,心力衰竭的指导指导医学疗法 (GDMT) 与减少喷射分数 (HFrEF) 的使用不足. 优化GDMT,特别是针对新发病的HFrEF,可以显著降低死亡率和再接收率.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 有证据表明,指南导向医学疗法 (GDMT) 可以改善心力衰竭患者的治疗结果,减少排气分数 (HFrEF).
- 尽管有证据,但GDMT在HFrEF护理中的实施仍然不足于最佳水平,需要进一步调查促成因素和临床影响.
研究的目的:
- 在急性HFrEF住院期间量化GDMT实施率.
- 分析社会经济因素与遵守GDMT之间的关系.
- 评估使用GDMT对后续临床事件的影响,包括死亡率和再接收.
主要方法:
- 一项回顾性研究分析了在2017年至2018年期间因HFrEF住院的成年患者中使用修改的最佳医疗疗 (mOMT) 评分来分析GDMT的利用率.
- 通过曼-惠特尼U和克鲁斯卡尔-瓦利斯测试,评估了社会经济因素与GDMT实施的关联.
- 单变量和多变量考克斯比例危险回归模型评估了出院mOMT得分和1年复合结果 (所有原因死亡率和HF再入院) 之间的关联.
主要成果:
- 只有12.5%的患者获得了近乎完美的出院mOMT得分,这表明GDMT实施范围普遍不够优.
- 黑人患者和无家可归的个人表现出明显较低的出院mOMT分数.
- 更高的排放mOMT得分与复合终点的降低率有关,0.1点的增加与9.2%的减少有关.
结论:
- 在HFrEF住院期间实施低于最佳的GDMT是普遍存在的,并且与不良的临床结果有关.
- 观察到GDMT优化的差异,黑人患者和那些经历无家可归的人不太可能接受优化治疗.
- 在住院期间改善GDMT的坚持对于改善HFrEF患者的治疗结果至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
01:22Heart Failure Drugs: β-Blockers
326
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
01:22Heart Failure Drugs: Diuretics
353
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353
01:26Heart Failure Drugs: Inotropic Agents
548
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
548
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:11Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77